Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases

Wei Zhou, Erek D. Nelson, Anan A. Abu Rmilah, Bruce P. Amiot, Scott L. Nyberg

Research output: Contribution to journalReview article

Abstract

Owing to the increasing worldwide burden of liver diseases, the crucial need for safe and effective interventions for treating end-stage liver failure has been a very productive line of inquiry in the discipline of hepatology for many years. Liver transplantation is recognized as the most effective treatment for end-stage liver disease; however, the shortage of donor organs, high medical costs, and lifelong use of immunosuppressive agents represent major drawbacks and demand exploration for alternative treatments. Stem cell-based therapies have been widely studied in the field of liver diseases and are considered to be among the most promising therapies. Herein, we review recent advances in the application of stem cell-related therapies in liver disease with the aim of providing readers with relevant knowledge in this field and inspiration to spur further inquiry.

Original languageEnglish (US)
Pages (from-to)1116-1122
Number of pages7
JournalCell Transplantation
Volume28
Issue number9-10
DOIs
StatePublished - Sep 1 2019

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Liver
Liver Diseases
Stem Cells
End Stage Liver Disease
Liver Failure
Gastroenterology
Immunosuppressive Agents
Liver Transplantation
Therapeutics
Tissue Donors
Costs and Cost Analysis
Costs

Keywords

  • cellular therapy
  • hepatology

ASJC Scopus subject areas

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases. / Zhou, Wei; Nelson, Erek D.; Abu Rmilah, Anan A.; Amiot, Bruce P.; Nyberg, Scott L.

In: Cell Transplantation, Vol. 28, No. 9-10, 01.09.2019, p. 1116-1122.

Research output: Contribution to journalReview article

Zhou, Wei ; Nelson, Erek D. ; Abu Rmilah, Anan A. ; Amiot, Bruce P. ; Nyberg, Scott L. / Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases. In: Cell Transplantation. 2019 ; Vol. 28, No. 9-10. pp. 1116-1122.
@article{f58c1ab29cdf4e278a95b576a5ea0315,
title = "Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases",
abstract = "Owing to the increasing worldwide burden of liver diseases, the crucial need for safe and effective interventions for treating end-stage liver failure has been a very productive line of inquiry in the discipline of hepatology for many years. Liver transplantation is recognized as the most effective treatment for end-stage liver disease; however, the shortage of donor organs, high medical costs, and lifelong use of immunosuppressive agents represent major drawbacks and demand exploration for alternative treatments. Stem cell-based therapies have been widely studied in the field of liver diseases and are considered to be among the most promising therapies. Herein, we review recent advances in the application of stem cell-related therapies in liver disease with the aim of providing readers with relevant knowledge in this field and inspiration to spur further inquiry.",
keywords = "cellular therapy, hepatology",
author = "Wei Zhou and Nelson, {Erek D.} and {Abu Rmilah}, {Anan A.} and Amiot, {Bruce P.} and Nyberg, {Scott L.}",
year = "2019",
month = "9",
day = "1",
doi = "10.1177/0963689719859262",
language = "English (US)",
volume = "28",
pages = "1116--1122",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "9-10",

}

TY - JOUR

T1 - Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases

AU - Zhou, Wei

AU - Nelson, Erek D.

AU - Abu Rmilah, Anan A.

AU - Amiot, Bruce P.

AU - Nyberg, Scott L.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Owing to the increasing worldwide burden of liver diseases, the crucial need for safe and effective interventions for treating end-stage liver failure has been a very productive line of inquiry in the discipline of hepatology for many years. Liver transplantation is recognized as the most effective treatment for end-stage liver disease; however, the shortage of donor organs, high medical costs, and lifelong use of immunosuppressive agents represent major drawbacks and demand exploration for alternative treatments. Stem cell-based therapies have been widely studied in the field of liver diseases and are considered to be among the most promising therapies. Herein, we review recent advances in the application of stem cell-related therapies in liver disease with the aim of providing readers with relevant knowledge in this field and inspiration to spur further inquiry.

AB - Owing to the increasing worldwide burden of liver diseases, the crucial need for safe and effective interventions for treating end-stage liver failure has been a very productive line of inquiry in the discipline of hepatology for many years. Liver transplantation is recognized as the most effective treatment for end-stage liver disease; however, the shortage of donor organs, high medical costs, and lifelong use of immunosuppressive agents represent major drawbacks and demand exploration for alternative treatments. Stem cell-based therapies have been widely studied in the field of liver diseases and are considered to be among the most promising therapies. Herein, we review recent advances in the application of stem cell-related therapies in liver disease with the aim of providing readers with relevant knowledge in this field and inspiration to spur further inquiry.

KW - cellular therapy

KW - hepatology

UR - http://www.scopus.com/inward/record.url?scp=85072718379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072718379&partnerID=8YFLogxK

U2 - 10.1177/0963689719859262

DO - 10.1177/0963689719859262

M3 - Review article

C2 - 31240944

AN - SCOPUS:85072718379

VL - 28

SP - 1116

EP - 1122

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 9-10

ER -